Lymph Node Log-Odds Ratio Accurately Defines Prognosis in Resectable Non-Small Cell Lung Cancer

Simple Summary Non-small cell lung cancer is one of the most common malignancies with major challenges in diagnosis and treatment. Estimating individual prognosis is important in order to tailor the selected therapy to each patient. Lymph node involvement represents a crucial factor which is associated with long-term survival. The currently used classifications of lymph node involvement are anatomically conditioned and do not consider the number of positive lymph nodes and their association with non-involved lymph nodes. In this study we investigated the effect of a mathematical formula (log-odds ratio), including the ratio of positive and negative lymph nodes on survival. We found that this new score is significantly associated with survival in resectable non-small cell lung cancer and might better reflect the individual prognosis. Abstract Objectives: The ratio of positive and resected lymph nodes (LN ratio) has been shown to be prognostic in non-small cell lung cancer (NSCLC). Contrary to the LN ratio, calculating the LN log-odds ratio (LN-LOR) additionally considers the total number of resected lymph nodes. We aim to evaluate LN-LOR between positive and resected lymph nodes as a prognostic factor in operable NSCLC. Methods: Patients with NSCLC who underwent curative intent lobectomy treated at two high-volume centers were retrospectively studied. LN-LOR was dichotomized according to impact on OS and further combined with N descriptors and correlated with clinical variables and survival. Results: 944 patients were included. Cut-off analysis revealed that an LN-LOR of −0.34 significantly discriminated patients according to OS (p < 0.001, chi-squared test 41.26). When combined with N1 and N2 descriptors, LN-LOR low risk (median OS not reached and 83 months) and LN-LOR high-risk patients (median OS 50 and 59 months) had similar survival irrespective of the anatomical location of the positive lymph nodes. Multivariable Cox regression analysis revealed that age (HR 1.02, 95% CI 1.001–1.032), sex (male, HR 1.65, 95% CI 1.25–2.19), histological subtype (HR 2.11, 95% CI 1.35–3.29), pathological stage (HR 1.23, 95% CI 1.01–1.45) and LN-LOR risk groups (low risk, HR 0.48, 95% CI 0.32–0.72) were independent prognostic factors for OS. Conclusions: This retrospective two-center analysis shows that LN-LOR is significantly associated with OS in resectable NSCLC and might better reflect the biological behavior of the disease, regardless of anatomical lymph node locations. This finding may additionally support the value of extensive LN dissection.

[1]  Yongbing Chen,et al.  Log odds of positive lymph nodes is a robust predictor of survival and benefits from postoperative radiotherapy in stage IIIA‐N2 resected non‐small cell lung cancer , 2022, Thoracic cancer.

[2]  W. Klepetko,et al.  Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study , 2022, ESMO open.

[3]  D. Dziedzic,et al.  Alternative methods of lymph node staging in lung cancer: a narrative review , 2020, Journal of thoracic disease.

[4]  Lunxu Liu,et al.  Prognostic value of lymph node ratio in non-small-cell lung cancer: a meta-analysis. , 2019, Japanese journal of clinical oncology.

[5]  F. Mucilli,et al.  Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis† , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[6]  Z. Liao,et al.  Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer. , 2018, Lung cancer.

[7]  Zhentao Yu,et al.  Log odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection. , 2017, Journal of thoracic disease.

[8]  D. Dziedzic,et al.  Log odds of positive lymph nodes as a novel prognostic indicator in NSCLC staging. , 2017, Surgical oncology.

[9]  Haiquan Chen,et al.  The prognostic value of lymph node ratio and log odds of positive lymph nodes in patients with lung adenocarcinoma , 2017, The Journal of thoracic and cardiovascular surgery.

[10]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[11]  Hisao Asamura,et al.  The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  Jyh‐cherng Yu,et al.  Prognostic value of the lymph node ratio in breast cancer subtypes. , 2015, American journal of surgery.

[14]  Guangyuan Sun,et al.  Lymph node ratio is a prognostic factor for non-small cell lung cancer , 2015, Oncotarget.

[15]  J. Dunning,et al.  Statistical and data reporting guidelines for the European Journal of Cardio-Thoracic Surgery and the Interactive CardioVascular and Thoracic Surgery. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  H. Zhang,et al.  Lymph node ratio-based staging system for esophageal squamous cell carcinoma. , 2015, World journal of gastroenterology.

[17]  O. Kutlu,et al.  Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients. , 2015, Surgical oncology.

[18]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[19]  P. Zhang,et al.  Log odds of positive lymph nodes are superior to other measures for evaluating the prognosis of non‐small cell lung cancer , 2014, Thoracic cancer.

[20]  C. Dooms,et al.  Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[21]  R. Osarogiagbon,et al.  Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non-small cell lung cancer. , 2014, The Annals of thoracic surgery.

[22]  David R. Jones,et al.  Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer. , 2013, The Annals of thoracic surgery.

[23]  J. Usuda,et al.  A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer. , 2013, Chest.

[24]  A. Biondi,et al.  Log Odds of Positive Lymph Nodes in Colon Cancer: A Meaningful Ratio-based Lymph Node Classification System , 2012, World Journal of Surgery.

[25]  F. Tanaka,et al.  Clinical significance in the number of involved lymph nodes in patients that underwent surgery for pathological stage III-N2 non-small cell lung cancer , 2011, Journal of cardiothoracic surgery.

[26]  Shun‐ichi Watanabe,et al.  Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage Classification? , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[27]  Hui-mian Xu,et al.  Log odds of positive lymph nodes , 2010, Cancer.

[28]  Hisao Asamura,et al.  The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[29]  J. Hassett,et al.  The Prognostic Superiority of Log Odds of Positive Lymph Nodes in Stage III Colon Cancer , 2008, Journal of Gastrointestinal Surgery.

[30]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[31]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[32]  P. V. Van Schil,et al.  ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[33]  W. Woodward,et al.  Prognostic value of nodal ratios in node-positive breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  T. Mitsudomi,et al.  Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer , 2006, Journal of Thoracic Oncology.